Nano Miscellaneous
Market Cap
₹4 ₹4.00 Cr.
P/E
0.00
PEG = P/E ÷ 5yr forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

Key Ratios

Shareholders Funds
Shareholders Funds
44.54 Cr
Net Sales
Net Sales
11.76 Cr
Total Income
Total Income
14.17 Cr
Cash from Operating Activity
Cash from Operating Activity
-14.62 Cr
ROE
ROE
0.20 %
ROCE
ROCE
0.29 %
Dividend Yield
Dividend Yield
0.00 %
Debt to Equity Ratio
Debt to Equity Ratio
0.00
EV by EBITDA
EV by EBITDA
-
Gross Margin
Gross Margin
-11.27 %
Interest Coverage Ratios
Interest Coverage Ratios
-
ROCE 3yr Avg
ROCE 3yr Avg
3.98 %
Institutions
Institutions
0.00 %
Promoter
Promoter
0.02 %
  • EVOQ Remedies
  • Dipna Pharmachem
  • Deccan Health Care

Nothing to show here

This view can't be shown right now. We're continuously expanding and updating coverage across companies, so please check back again soon.

Nothing to show here

This view can't be shown right now. We're continuously expanding and updating coverage across companies, so please check back again soon.

Price Range
Low
1
52W Range
High
4
Key company specific updates.

Nothing to show here

This view isn't available yet. We're continuously expanding our company coverage, so check back soon for updates.

Custom financial statement

Edit rows

Forensics

6 Yes

Positive for this company

1 Neutral

Neutral for this company

7 No

Negative for this company

3 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison

FAQs on EVOQ Remedies Ltd. Business

EVOQ Remedies Ltd. specializes in providing Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs with a team of industry experts ensuring quality and affordability through certified manufacturers and importers.

EVOQ Remedies major competitors are Dipna Pharmachem, Deccan Health Care, Bharat Immunological, JFL Life Sciences, Vivimed Labs, Biofil Chem & Pharma, Denis Chem Lab.
Market Cap of EVOQ Remedies is ₹4 Crs.
While the median market cap of its peers are ₹44 Crs.

EVOQ Remedies seems to be less financially stable compared to its competitors.
Altman Z score of EVOQ Remedies is 2.19 and is ranked 5 out of its 8 competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material